MedPath

Penicillamine

Generic Name
Penicillamine
Brand Names
Cuprimine, Depen
Drug Type
Small Molecule
Chemical Formula
C5H11NO2S
CAS Number
52-67-5
Unique Ingredient Identifier
GNN1DV99GX

Overview

Penicillamine is a pharmaceutical of the chelator class. The pharmaceutical form is D-penicillamine, as L-penicillamine is toxic (it inhibits the action of pyridoxine). It is an α-amino acid metabolite of penicillin, although it has no antibiotic properties.

Background

Penicillamine is a pharmaceutical of the chelator class. The pharmaceutical form is D-penicillamine, as L-penicillamine is toxic (it inhibits the action of pyridoxine). It is an α-amino acid metabolite of penicillin, although it has no antibiotic properties.

Indication

For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis.

Associated Conditions

  • Cystinuria
  • Lead Poisoning
  • Wilson's Disease
  • Refractory Rheumatoid arthritis
  • Severe Rheumatoid arthritis

FDA Approved Products

Penicillamine
Manufacturer:ANI Pharmaceuticals, Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2021/07/01
NDC:62559-970
Penicillamine
Manufacturer:Navinta LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2022/12/02
NDC:68475-201
Penicillamine
Manufacturer:Proficient Rx LP
Route:ORAL
Strength:250 mg in 1 1
Approved: 2022/04/01
NDC:71205-916
Penicillamine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:250 mg in 1 1
Approved: 2022/12/06
NDC:72162-2112
Depen
Manufacturer:Meda Pharmaceuticals Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2019/01/17
NDC:0037-4401

Singapore Approved Products

CUPRIPEN 250 CAPSULE 250 mg
Manufacturer:LABORATORIOS RUBIO SA
Form:CAPSULE
Strength:250 mg
Online:Yes
Approved: 1995/05/17
Approval:SIN08173P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath